MY123908A - Meta-azacyclic amino benzoic acid compounds and derivatives thereof - Google Patents

Meta-azacyclic amino benzoic acid compounds and derivatives thereof

Info

Publication number: MY123908A
Authority: MY; Malaysia
Prior art keywords: meta; derivatives; benzoic acid; acid compounds; amino benzoic
Prior art date: 1998-03-04

Application number

MYPI99000772A

Other languages

English (en)

Inventor

Thomas E Rogers

Peter G Ruminksi

Original Assignee

Searle & Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-04

Filing date

1999-03-03

Publication date

2006-06-30

1999-03-03 Application filed by Searle & Co filed Critical Searle & Co

2006-06-30 Publication of MY123908A publication Critical patent/MY123908A/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
- C07D239/12—Nitrogen atoms not forming part of a nitro radical
- C07D239/14—Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to said nitrogen atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Oncology (AREA)
Endocrinology (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Indole Compounds (AREA)

MYPI99000772A 1998-03-04 1999-03-03 Meta-azacyclic amino benzoic acid compounds and derivatives thereof MY123908A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US3427098A	1998-03-04	1998-03-04

Publications (1)

Publication Number	Publication Date
MY123908A true MY123908A (en)	2006-06-30

Family

ID=21875345

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MYPI99000772A MY123908A (en)	1998-03-04	1999-03-03	Meta-azacyclic amino benzoic acid compounds and derivatives thereof

Country Status (29)

Country	Link
EP (1)	EP1060164A1 (xx)
JP (1)	JP2002505323A (xx)
KR (1)	KR20010041584A (xx)
CN (1)	CN1214011C (xx)
AP (1)	AP1244A (xx)
AR (1)	AR018139A1 (xx)
AU (1)	AU753230B2 (xx)
BG (1)	BG104740A (xx)
BR (1)	BR9908470A (xx)
CA (1)	CA2322207A1 (xx)
EA (1)	EA200000804A1 (xx)
EE (1)	EE200000506A (xx)
GE (1)	GEP20033118B (xx)
HR (1)	HRP20000574A2 (xx)
HU (1)	HUP0100865A3 (xx)
ID (1)	ID25591A (xx)
IL (1)	IL137653A0 (xx)
IS (1)	IS5582A (xx)
MY (1)	MY123908A (xx)
NO (1)	NO315703B1 (xx)
NZ (1)	NZ506598A (xx)
OA (1)	OA11530A (xx)
PL (1)	PL342726A1 (xx)
SK (1)	SK13002000A3 (xx)
TR (1)	TR200002542T2 (xx)
UA (1)	UA71906C2 (xx)
WO (1)	WO1999044994A1 (xx)
YU (1)	YU52000A (xx)
ZA (1)	ZA994406B (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9805655D0 (en)	1998-03-16	1998-05-13	Celltech Therapeutics Ltd	Chemical compounds
GB9814414D0 (en)	1998-07-03	1998-09-02	Celltech Therapeutics Ltd	Chemical compounds
GB9821061D0 (en)	1998-09-28	1998-11-18	Celltech Therapeutics Ltd	Chemical compounds
GB9826174D0 (en)	1998-11-30	1999-01-20	Celltech Therapeutics Ltd	Chemical compounds
US6518283B1 (en)	1999-05-28	2003-02-11	Celltech R&D Limited	Squaric acid derivatives
US6455539B2 (en)	1999-12-23	2002-09-24	Celltech R&D Limited	Squaric acid derivates
ES2295150T3 (es)	2000-04-17	2008-04-16	Ucb Pharma, S.A.	Derivados de enamina como moleculas de adhesion celular.
US6545013B2 (en)	2000-05-30	2003-04-08	Celltech R&D Limited	2,7-naphthyridine derivatives
US6403608B1 (en)	2000-05-30	2002-06-11	Celltech R&D, Ltd.	3-Substituted isoquinolin-1-yl derivatives
US6921767B2 (en) *	2000-06-15	2005-07-26	Pharmacia Corporation	Cycloalkyl alkanoic acids as integrin receptor antagonists derivatives
AU2001275724A1 (en)	2000-08-02	2002-02-13	Celltech R&D Limited	3-substituted isoquinolin-1-yl derivatives
BR0317487A (pt) *	2002-12-20	2005-11-29	Pharmacia Corp	O r-isÈmero de compostos de aminoácido beta como derivados de antagonistas de receptores de integrina
UA87854C2 (xx)	2004-06-07	2009-08-25	Мерк Энд Ко., Инк.	N-(2-бензил)-2-фенілбутанаміди як модулятори рецептора андрогену$n-(2-бензил)-2-фенилбутанамиды как модуляторы рецептора андрогена
BRPI0611814A2 (pt) *	2005-06-10	2008-12-09	Bipar Sciences Inc	moduladores parp e tratamento de cÂnceres
JP2010520238A (ja)	2007-03-01	2010-06-10	マリンクロットインコーポレイテッド	統合された光活性低分子および統合された光活性低分子使用
JP4792124B1 (ja) *	2010-11-15	2011-10-12	エフイートレード株式会社	車両用保護フィルムの型取り方法、及び、車両用保護フィルムの製造方法
IN2015DN00099A (xx)	2012-07-18	2015-05-29	Univ Saint Louis
US8716226B2 (en)	2012-07-18	2014-05-06	Saint Louis University	3,5 phenyl-substituted beta amino acid derivatives as integrin antagonists
MX2016015467A (es)	2014-05-30	2017-03-23	Pfizer	Derivados de carbonitrilo como moduladores selectivos del receptor de androgenos.
CN106659162B (zh) *	2014-06-04	2020-10-27	孟山都技术公司	3,6-二氯水杨酸化合物以及相关合成方法
CN108779077A (zh)	2015-12-30	2018-11-09	圣路易斯大学	作为pan整合素拮抗剂的间位氮杂环氨基苯甲酸衍生物
JP7661969B2 (ja)	2020-05-14	2025-04-15	Ｕｂｅ株式会社	１，４，５，６－テトラヒドロピリミジン－２－アミン誘導体
WO2023275715A1 (en)	2021-06-30	2023-01-05	Pfizer Inc.	Metabolites of selective androgen receptor modulators
EP4431098A4 (en)	2021-11-12	2025-10-08	Ube Corp	PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF ALPORT SYNDROME

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH11510814A (ja) *	1995-08-30	1999-09-21	ジー．ディー．サールアンドカンパニー	インテグリンアンタゴニストとしてのメタ−グアニジン、尿素、チオ尿素またはアザ環状アミノ安息香酸誘導体

1999
- 1999-02-11 ZA ZA9904406A patent/ZA994406B/xx unknown
- 1999-02-22 OA OA1200000238A patent/OA11530A/en unknown
- 1999-02-22 EP EP99937927A patent/EP1060164A1/en active Pending
- 1999-02-22 ID IDW20001695A patent/ID25591A/id unknown
- 1999-02-22 WO PCT/US1999/003281 patent/WO1999044994A1/en not_active Ceased
- 1999-02-22 JP JP2000534538A patent/JP2002505323A/ja active Pending
- 1999-02-22 HU HU0100865A patent/HUP0100865A3/hu unknown
- 1999-02-22 YU YU52000A patent/YU52000A/sh unknown
- 1999-02-22 CA CA002322207A patent/CA2322207A1/en not_active Abandoned
- 1999-02-22 TR TR2000/02542T patent/TR200002542T2/xx unknown
- 1999-02-22 KR KR1020007009774A patent/KR20010041584A/ko not_active Ceased
- 1999-02-22 AU AU32947/99A patent/AU753230B2/en not_active Ceased
- 1999-02-22 HR HR20000574A patent/HRP20000574A2/hr not_active Application Discontinuation
- 1999-02-22 NZ NZ506598A patent/NZ506598A/en unknown
- 1999-02-22 GE GEAP19995537A patent/GEP20033118B/en unknown
- 1999-02-22 SK SK1300-2000A patent/SK13002000A3/sk unknown
- 1999-02-22 BR BR9908470-8A patent/BR9908470A/pt not_active Application Discontinuation
- 1999-02-22 UA UA2000095148A patent/UA71906C2/uk unknown
- 1999-02-22 IL IL13765399A patent/IL137653A0/xx unknown
- 1999-02-22 EA EA200000804A patent/EA200000804A1/ru unknown
- 1999-02-22 EE EEP200000506A patent/EE200000506A/xx unknown
- 1999-02-22 PL PL99342726A patent/PL342726A1/xx unknown
- 1999-02-22 AP APAP/P/2000/001893A patent/AP1244A/en active
- 1999-02-22 CN CNB998035815A patent/CN1214011C/zh not_active Expired - Fee Related
- 1999-03-02 AR ARP990100880A patent/AR018139A1/es unknown
- 1999-03-03 MY MYPI99000772A patent/MY123908A/en unknown
2000
- 2000-08-04 IS IS5582A patent/IS5582A/is unknown
- 2000-08-30 NO NO20004316A patent/NO315703B1/no not_active IP Right Cessation
- 2000-09-01 BG BG104740A patent/BG104740A/xx unknown

Also Published As

Publication number	Publication date
CA2322207A1 (en)	1999-09-10
AP2000001893A0 (en)	2000-09-30
CN1214011C (zh)	2005-08-10
NO315703B1 (no)	2003-10-13
PL342726A1 (en)	2001-07-02
HRP20000574A2 (en)	2001-08-31
TR200002542T2 (tr)	2001-05-21
SK13002000A3 (sk)	2001-07-10
AP1244A (en)	2004-02-04
ID25591A (id)	2000-10-19
YU52000A (sh)	2003-02-28
BR9908470A (pt)	2000-12-05
BG104740A (en)	2001-02-28
OA11530A (en)	2004-05-17
AU753230B2 (en)	2002-10-10
IS5582A (is)	2000-08-04
HUP0100865A2 (hu)	2001-08-28
AR018139A1 (es)	2001-10-31
ZA994406B (en)	2000-02-11
EA200000804A1 (ru)	2001-04-23
NO20004316L (no)	2000-11-06
AU3294799A (en)	1999-09-20
NO20004316D0 (no)	2000-08-30
HUP0100865A3 (en)	2001-11-28
UA71906C2 (en)	2005-01-17
CN1291978A (zh)	2001-04-18
EP1060164A1 (en)	2000-12-20
IL137653A0 (en)	2001-10-31
EE200000506A (et)	2002-04-15
KR20010041584A (ko)	2001-05-25
WO1999044994A1 (en)	1999-09-10
JP2002505323A (ja)	2002-02-19
GEP20033118B (en)	2003-11-25
NZ506598A (en)	2003-07-25

Publication	Publication Date	Title
MY123908A (en)	2006-06-30	Meta-azacyclic amino benzoic acid compounds and derivatives thereof
FI950309A0 (fi)	1995-01-24	Proliiniamidijohdannaisia
TR200200579T2 (tr)	2002-12-23	Amino-tirazolpiridin türevleri.
DE69831868D1 (en)	2006-02-23	Antithrombosemittel
ATE297203T1 (de)	2005-06-15	Antithrombotische mitteln
EA200200619A1 (ru)	2002-10-31	Непептидильные ингибиторы vla-4-зависимого связывания клеток, применяемые при лечении воспалительных, аутоимунных и респираторных заболеваний
ATE272633T1 (de)	2004-08-15	Aromatische amiden
DE69705300D1 (de)	2001-07-26	Cyclopropylalkansäurederivate
GR3033661T3 (en)	2000-10-31	Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo(c)azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace
AU4831899A (en)	2000-01-17	5-HT1F agonists
SI1181294T1 (en)	2004-08-31	Novel derivatives and analogues of galanthamin
IL136100A (en)	2005-05-17	Biphenylamidine derivatives and pharmaceutical compositions containing the same
EP1019047A4 (en)	2001-06-13	ANTITHROMBOTIC AGENTS
NO983444D0 (no)	1998-07-24	Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer
EP1027051A4 (en)	2001-03-07	ANTITHROMBOTIC AGENTS
ZA951013B (en)	1995-10-19	Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase
ATE282608T1 (de)	2004-12-15	Chinoxalindionen
ATE222583T1 (de)	2002-09-15	Derivate substituierter amidinonaphthylester
YU43499A (sh)	2000-12-28	Kristalna hidratovana natrijumova so (e)-4,6-dihloro-3- (2-okso-1-fenilpirolidin-3-iliden metil)-1h-indol-2- karboksilne kiseline
ZA94183B (en)	1994-08-18	Ketorolac derivatives with considerably reduced gastro-intestinal irritation and ulceration
DE69824410D1 (en)	2004-07-15	Antithrombosemittel